1.
Clin Infect Dis
; 76(3): e1261-e1265, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35974429
RESUMO
We report on 11 critically ill burn patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections. Clinical success was achieved in 36% and complicated by treatment-emergent resistance and interpatient transmission of cefiderocol-resistant A. baumannii. Resistant isolates harbored disrupted pirA and piuA genes that were not disrupted among susceptible isolates.